Nano-X Imaging Secures $15 Million in Registered Direct Offering to Advance Medical Imaging Technology

Nano-X Imaging Ltd. (NASDAQ: NNOX) has entered into a securities purchase agreement with a single institutional investor for a registered direct offering that is expected to generate approximately $15 million in gross proceeds. The company will sell 3,826,530 ordinary shares in this offering, with Titan Partners Group, a division of American Capital Partners, serving as the sole placement agent. The closing of this transaction is anticipated to occur on or about November 25, 2025.

The net proceeds from this offering are designated for working capital and general corporate purposes, supporting Nano-X's ongoing mission to transform preventive healthcare through innovative medical imaging technologies. This financial infusion comes at a critical time for the medical technology sector, where advancements in imaging and artificial intelligence are increasingly important for early disease detection and treatment.

Nano-X's comprehensive ecosystem represents a significant shift in medical imaging accessibility and efficiency. The company's flagship technology, Nanox.ARC, is a multi-source digital tomosynthesis system designed to be both cost-effective and user-friendly, potentially expanding medical imaging capabilities beyond traditional hospital settings. This approach could have substantial implications for healthcare systems worldwide by making diagnostic imaging more accessible in underserved areas and reducing overall healthcare costs.

The company's artificial intelligence capabilities, developed through Nanox.AI LTD, provide a suite of algorithms that enhance the interpretation of routine CT imaging. These AI tools are engineered to identify early indicators often associated with chronic diseases, potentially improving diagnostic accuracy and enabling earlier intervention. The integration of AI in medical imaging represents a growing trend in healthcare technology that could significantly impact patient outcomes and treatment efficiency.

Nanox.CLOUD serves as the central platform for managing and storing data collected by Nanox devices, while also providing users with sophisticated tools for in-depth imaging analysis. This cloud-based infrastructure supports the company's vision of creating a seamless end-to-end solution from scan to diagnosis. The platform's capabilities align with the broader healthcare industry's movement toward digital transformation and data-driven medical decision-making.

Through its subsidiary, USARAD Holdings Inc., Nano-X operates Nanox.MARKETPLACE, a proprietary decentralized marketplace that provides remote access to radiology and cardiology experts. This teleradiology services platform could potentially address specialist shortages in certain regions and improve access to expert medical opinions. The combination of advanced imaging technology with remote specialist access represents an innovative approach to healthcare delivery that could have far-reaching implications for global health equity.

The $15 million capital raise through this registered direct offering positions Nano-X to continue developing and expanding its technology ecosystem. For more information about Nano-X Imaging and its technologies, visit https://www.nanox.vision/. The company's focus on preventive healthcare through affordable medical imaging solutions comes at a time when healthcare systems worldwide are seeking more efficient and accessible diagnostic tools to improve population health outcomes.